Page 172 - product-manual
P. 172

TM/MC  TM/MC
                                          PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                                     Siraitia grosvenorii  [Momordica grosvenori] (Monk Fruit)

                                     In traditional Chinese medicine Fructus Momordicae grosvenorii is used as an expectorant and
                                     antitussive, to treat lung congestion, cough and other respiratory ailments. These therapeutic
                                     benefits are attributed to the unique component of Fructus Momordicae grosvenorii which are
                                     the triterpene glycosides, most importantly mogroside-5 (Dharmananda, 2004). Mogroside-5
                                     has also been reported to be an antioxidant agent that can scavenge reactive oxygen species and
                                     prevent DNA damage (Zhang et al., 2011).



                    Toxicity for Fructus Momordicae grosvenorii has not been documented in dogs and cats when administered orally
                TOXICOLOGY  2011).           50
                    in therapeutic doses. Oral LD  of Fructus Momordicae grosvenorii is >10 g/kg of body weight in mice (Nabors,



                    Equivalent toxic dose in 20 kg dog:   >200 g PO of Fructus Momordicae grosvenorii.
                    Equivalent toxic dose in 5 kg cat:    >50 g PO of Fructus Momordicae grosvenorii.


                            DRUG     Validated interactions studies do not exist for Fructus Momordicae grosvenorii preparations.
                   INTERACTIONS      Clinical interactions with other drugs have not been reported.







            Verbascum thapsus (Mullein)


            From  antiquity  Verbascum  thapsus  has  been  used  as  a  medicinal  herb,  it  contains  diverse
            polysaccharides,  iroid  glycosides,  flavonoids,  saponins,  volatile  oils  and  phenylentanoids.
            Verbascoside has anti-inflammatory properties since it reduces the production of superoxide
            radicals  and  consequently  reduces  the  activity  of  inducible  nitric  oxide  synthase  [iNOS]
            (Speranza et al., 2010). Flos Verbasci has been used for the treatment of inflammatory diseases,
            asthma, spasmodic coughs, and other pulmonary problems. Aqueous extracts of Flos Verbasci
            has  exhibited  antibacterial  activity  against  Klebsiella  pneumonia,  Staphylococcus  aureus,
            Staphylococcus epidermidis, and Escherichia coli (Turker & Camper, 2002).



                TOXICOLOGY  Toxicity for Flos Verbasci has not been documented in dogs and cats when administered orally in therapeutic
                    doses. Oral LD  of ethanol extract of Verbascum thapsus is >400 mg/kg in rats (Murti et al., 2011).
                                 50
                    Equivalent toxic dose in 20 kg dog:   >8000 mg PO of ethanol extract of Verbascum thapsus.
                                                    >2000 mg PO of ethanol extract of Verbascum thapsus.
                    Equivalent toxic dose in 5 kg cat:


                             DRUG     Validated interactions studies do not exist for Flos Verbasci preparations. Clinical interactions
                    INTERACTIONS      with other drugs have not been reported.




                                                                                                   Pulmo -VM TM       |  7
   167   168   169   170   171   172   173   174   175   176   177